Risk Factors for Liver Failure from Immunosuppressive Therapy-induced Hepatitis B Virus Reactivation

• 作 者: Xianli Chen
• 机 构: InstituteforInfectiousDiseases,SouthwestHospital,ThirdMilitaryMedicalUniversity
• 出 处: 中华医学会第十七次全国病毒性肝炎及肝病学术会议暨2015年中华医学会感染病学分会年会、中华医学会肝病学分会年会
• 发表日期: 2015年10期
• 关键词: Hepatitis B virus reactivation Nucleoside analogues

　　Objective: Hepatitis B virus reactivation(HBVr)is a known complication of immunosuppressive therapy in transplantation,autoimmune disease,chemotherapy.The risk of developing HBVr-related liver failure is not clear.This study describes the risk factors of HBVr-related liver failure.Results: Methods: From 2001 to 2013,all 195 HBVr patients undergoing immunosuppressive therapy in Southwest Hospital were included in this retrospective study.